Palvella director granted 3,000 stock options
Palvella Therapeutics director Elaine J. Heron received a grant of stock options for 3,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Palvella Therapeutics director Elaine J. Heron received a grant of stock options for 3,000 shares of common stock. These options carry an exercise price of $102.19 per share and expire on June 10, 2036.
The options vest upon the earlier of the first anniversary of the June 10, 2026 grant date or the company’s next annual meeting of stockholders, subject to Heron’s continued service through the applicable vesting date. Following this grant, Heron holds 3,000 stock options directly.
Insider Trade Summary
Grant/Award: 3,000 shares
Grant/Award
1 txn
Insider
HERON ELAINE J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 3,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest upon the earlier of (i) the first anniversary of the grant date or (ii) the date of the Issuer's next annual meeting of stockholders following the grant date, subject in each case to the Reporting Person's continued service through the applicable vesting date.
Key Figures
Options granted: 3,000 options
Exercise price: $102.19 per share
Expiration date: June 10, 2036
+2 more
5 metrics
Options granted
3,000 options
Stock Option (Right to Buy) grant on June 10, 2026
Exercise price
$102.19 per share
Conversion or exercise price of granted options
Expiration date
June 10, 2036
Option term end date
Underlying shares
3,000 shares
Common stock underlying the options
Post-grant derivative holdings
3,000 options
Total stock options held following the transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, annual meeting of stockholders
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "102.1900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to this option shall vest upon the earlier of (i) the first anniversary of the grant date or (ii) the date of the Issuer's next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"the date of the Issuer's next annual meeting of stockholders following the grant date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Palvella Therapeutics (PVLA) report for Elaine J. Heron?
Palvella Therapeutics reported that director Elaine J. Heron received a grant of stock options for 3,000 shares of common stock. These options were awarded as compensation, not purchased in the open market, and represent a new derivative position for Heron.
What is the exercise price of Elaine J. Heron’s Palvella (PVLA) stock options?
Elaine J. Heron’s stock options have an exercise price of $102.19 per share. This is the fixed price at which she may buy Palvella common stock if the options vest and are exercised before their expiration date.
When do Elaine J. Heron’s Palvella (PVLA) stock options vest?
The stock options vest on the earlier of the first anniversary of the June 10, 2026 grant date or the date of Palvella’s next annual stockholder meeting. Vesting also requires Heron to remain in service through the applicable vesting date.
When do the Palvella (PVLA) stock options granted to Elaine J. Heron expire?
The stock options granted to Elaine J. Heron expire on June 10, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to purchase Palvella Therapeutics common stock at the $102.19 exercise price.
How many Palvella (PVLA) stock options does Elaine J. Heron hold after this filing?
Following this grant, Elaine J. Heron holds 3,000 stock options directly. Each option represents the right to purchase one share of Palvella Therapeutics common stock at the fixed exercise price of $102.19, subject to the vesting conditions described in the award.
Is Elaine J. Heron’s Palvella (PVLA) stock option grant an open-market purchase or compensation award?
Elaine J. Heron’s transaction is a compensation award, classified as a grant or other acquisition. The options were not bought in the open market; they were issued by Palvella as part of her service as a director, with vesting tied to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates